These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37983894)

  • 1. Satellite-Type Sulfur Atom Distribution in Trithiocarbonate Bond-Bridged Dimeric Prodrug Nanoassemblies: Achieving Both Stability and Activatability.
    Li L; Liu T; Zuo S; Li Y; Zhao E; Lu Q; Wang D; Sun Y; He Z; Sun B; Sun J
    Adv Mater; 2024 Jan; 36(4):e2310633. PubMed ID: 37983894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity.
    Yang Y; Sun B; Zuo S; Li X; Zhou S; Li L; Luo C; Liu H; Cheng M; Wang Y; Wang S; He Z; Sun J
    Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33148644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment.
    Liu T; Li L; Wang S; Dong F; Zuo S; Song J; Wang X; Lu Q; Wang H; Zhang H; Cheng M; Liu X; He Z; Sun B; Sun J
    Nat Commun; 2022 Nov; 13(1):7228. PubMed ID: 36434014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
    Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
    Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities.
    Zuo S; Sun B; Yang Y; Zhou S; Zhang Y; Guo M; Sun M; Luo C; He Z; Sun J
    Small; 2020 Nov; 16(45):e2005039. PubMed ID: 33078579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy.
    Sun B; Luo C; Zhang X; Guo M; Sun M; Yu H; Chen Q; Yang W; Wang M; Zuo S; Chen P; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nat Commun; 2019 Jul; 10(1):3211. PubMed ID: 31324811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical roles of linker length in determining the chemical and self-assembly stability of SN38 homodimeric nanoprodrugs.
    Wang X; Liu T; Huang Y; Dong F; Li L; Song J; Zuo S; Zhu Z; Kamei KI; He Z; Sun B; Sun J
    Nanoscale Horiz; 2023 Jan; 8(2):235-244. PubMed ID: 36537183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon-Spaced Tandem-Disulfide Bond Bridge Design Addresses Limitations of Homodimer Prodrug Nanoassemblies: Enhancing Both Stability and Activatability.
    Zhang H; Liu T; Sun Y; Wang S; Wang W; Kuang Z; Duan M; Du T; Liu M; Wu L; Sun F; Sheng J; He Z; Sun J
    J Am Chem Soc; 2024 Aug; 146(32):22675-22688. PubMed ID: 39088029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety.
    Sun Y; Wang S; Li Y; Wang D; Zhang Y; Zhang H; Lei H; Liu X; Sun J; Sun B; He Z
    Acta Biomater; 2023 Feb; 157():417-427. PubMed ID: 36513247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment.
    Wang D; Huang Y; Yuan J; Wang S; Sheng J; Zhao Y; Zhang H; Wang X; Yu Y; Shi X; He Z; Liu T; Sun B; Sun J
    J Control Release; 2024 Nov; 375():47-59. PubMed ID: 39222794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the Role of Connecting Bonds and Modifying Chains in the Rational Design of Prodrug Nanoassemblies.
    Wang D; Du C; Wang S; Li L; Liu T; Song J; He Z; Zhai Y; Sun B; Sun J
    ACS Appl Mater Interfaces; 2022 Nov; 14(45):51200-51211. PubMed ID: 36397309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the fluorination effect on the self-assembly characteristics,
    Wang X; Yang B; Li L; Liu T; Zuo S; Chi D; He Z; Sun B; Sun J
    Theranostics; 2021; 11(16):7896-7910. PubMed ID: 34335971
    [No Abstract]   [Full Text] [Related]  

  • 14. Tetrasulfide bond boosts the anti-tumor efficacy of dimeric prodrug nanoassemblies.
    Zuo S; Liu T; Li L; Xu H; Guo J; Wang Q; Yang Y; He Z; Sun J; Sun B
    Cell Rep Med; 2024 Mar; 5(3):101432. PubMed ID: 38387464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies.
    Li L; Zuo S; Dong F; Liu T; Gao Y; Yang Y; Wang X; Sun J; Sun B; He Z
    Asian J Pharm Sci; 2021 May; 16(3):337-349. PubMed ID: 34276822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication.
    Liang B; Zhou D
    Drug Deliv; 2021 Dec; 28(1):2361-2372. PubMed ID: 34747277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.
    Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zwitterion-Driven Shape Program of Prodrug Nanoassemblies with High Stability, High Tumor Accumulation, and High Antitumor Activity.
    Li G; Sun B; Zheng S; Xu L; Tao W; Zhao D; Yu J; Fu S; Zhang X; Zhang H; Zhai Y; Luo C; Ding H; He Z; Sun J
    Adv Healthc Mater; 2021 Dec; 10(23):e2101407. PubMed ID: 34601824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity.
    Li Y; Pei Q; Cui B; Zhang H; Han L; Li W; Zhu W; Feng X; Xie Z
    J Nanobiotechnology; 2021 Dec; 19(1):441. PubMed ID: 34930288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.